Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Bluebird Bio (BLUE)

Bluebird Bio (BLUE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
SmarTrend Watching for Potential Rebound in Shares of Bluebird Bio Inc After 8.73% Loss

Bluebird Bio Inc (NASDAQ:BLUE) traded in a range yesterday that spanned from a low of $80.02 to a high of $85.50. Yesterday, the shares fell 8.7%, which took the trading range below the 3-day low of...

BLUE : 66.78 (-8.14%)
bluebird (BLUE) Q4 Earnings Miss Estimates, Revenues In Line

bluebird (BLUE) reports a wider-than-expected loss and in-line revenues for the fourth quarter of 2019.

BMY : 59.58 (-3.97%)
BLUE : 66.78 (-8.14%)
ADRO : 2.97 (-13.16%)
GH : 77.16 (-5.33%)
bluebird bio Reports Fourth Quarter and Full Year 2019 Financial Results and Highlights Operational Progress

--- Announced positive top-line data from pivotal Phase 2 KarMMa study of ide-cel in relapsed and refractory multiple myeloma -

BLUE : 66.78 (-8.14%)
bluebird bio Announces Upcoming Investor Events

bluebird bio, Inc. (NASDAQ: BLUE) today announced that members of the management team will present at the following upcoming investor conferences:

BLUE : 66.78 (-8.14%)
Watch for Bluebird Bio Inc to Potentially Pullback After Gaining 8.67% Yesterday

Bluebird Bio Inc (NASDAQ:BLUE) traded in a range yesterday that spanned from a low of $82.13 to a high of $87.55. Yesterday, the shares gained 8.7%, which took the trading range above the 3-day high...

BLUE : 66.78 (-8.14%)
Bluebird Bio Inc Set to Possibly Rebound After Yesterday's Selloff of 2.73%

Bluebird Bio Inc (NASDAQ:BLUE) traded in a range yesterday that spanned from a low of $79.90 to a high of $82.65. Yesterday, the shares fell 2.7%, which took the trading range below the 3-day low of...

BLUE : 66.78 (-8.14%)
Look for Shares of Bluebird Bio Inc to Potentially Rebound after Yesterday's 2.77% Sell Off

Bluebird Bio Inc (NASDAQ:BLUE) traded in a range yesterday that spanned from a low of $87.20 to a high of $91.42. Yesterday, the shares fell 2.8%, which took the trading range below the 3-day low of...

BLUE : 66.78 (-8.14%)
bluebird bio Announces Launch in Germany of ZYNTEGLO(TM) (autologous CD34+ cells encoding BA-T87Q-globin gene) Gene Therapy for Patients 12 Years and Older with Transfusion-Dependent B-Thalassemia Who Do Not Have B(0)/B(0)Genotype

--First qualified treatment center established at University Hospital of Heidelberg to provide ZYNTEGLO to patients

BLUE : 66.78 (-8.14%)
SmarTrend Watching for Potential Pullback in Shares of Bluebird Bio Inc After 2.99% Gain

Bluebird Bio Inc (NASDAQ:BLUE) traded in a range yesterday that spanned from a low of $91.00 to a high of $94.12. Yesterday, the shares gained 3.0%, which took the trading range above the 3-day high...

BLUE : 66.78 (-8.14%)
Bluebird Bio (BLUE) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Bluebird Bio (BLUE) closed at $91.77, marking a +1.75% move from the previous day.

BLUE : 66.78 (-8.14%)
Bluebird Bio Inc Shares Up 7.6% Since SmarTrend's Buy Recommendation (BLUE)

SmarTrend identified an Uptrend for Bluebird Bio Inc (NASDAQ:BLUE) on November 29th, 2019 at $82.48. In approximately 1 month, Bluebird Bio Inc has returned 7.60% as of today's recent price of $88.74....

BLUE : 66.78 (-8.14%)
Novo Nordisk's Shares Up in a Year on Pipeline Progress

Novo Nordisk's (NVO) shares have gained in the past year as it makes significant progress in pipeline development.

NVO : 59.49 (-2.64%)
MRK : 78.08 (-2.33%)
GILD : 72.66 (-2.73%)
BLUE : 66.78 (-8.14%)
Relatively Good Performance Detected in Shares of Myriad Genetics in the Biotechnology Industry (MYGN , XON , BLUE , ATRA , MNTA )

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

BLUE : 66.78 (-8.14%)
XON : 4.65 (-4.12%)
MYGN : 17.28 (-3.63%)
Bluebird Bio Inc Set to Possibly Pullback After Yesterday's Rally of 2.38%

Bluebird Bio Inc (NASDAQ:BLUE) traded in a range yesterday that spanned from a low of $89.33 to a high of $92.16. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high...

BLUE : 66.78 (-8.14%)
bluebird bio Announces Investor Events in January

bluebird bio, Inc. (NASDAQ: BLUE) today announced that members of the management team will present at the following upcoming investor conferences in January:

JPM : 121.37 (-4.16%)
BLUE : 66.78 (-8.14%)
Bluebird Bio Inc Rises 3.11% on Heavy Volume: Watch For Potential Pullback

Bluebird Bio Inc (NASDAQ:BLUE) traded in a range yesterday that spanned from a low of $91.76 to a high of $95.57. Yesterday, the shares gained 3.1%, which took the trading range above the 3-day high...

BLUE : 66.78 (-8.14%)
bluebird (BLUE) Catches Eye: Stock Jumps 6.8%

bluebird (BLUE) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.

BLUE : 66.78 (-8.14%)
ANIK : 41.12 (-2.67%)
Sage Therapeutic is Among the Companies in the Biotechnology Industry with the Best Relative Performance (SAGE , PBYI , BLUE , ATRA , REGN )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

BLUE : 66.78 (-8.14%)
PBYI : 10.03 (-5.47%)
SAGE : 52.01 (-18.29%)
Biotech Stock Roundup: ASH Data in Focus, Amgen Gets FDA Nod to Remicade Biosimilar

The biotech sector witnesses pipeline updates from the annual ASH meet.

GILD : 72.66 (-2.73%)
AMGN : 203.50 (-5.15%)
BLUE : 66.78 (-8.14%)
FATE : 28.79 (-9.69%)
VRTX : 223.30 (-3.77%)
REGN : 431.61 (-5.75%)
SAGE : 52.01 (-18.29%)
Fate (FATE) Announces Encouraging Data on Immunotherapies

Fate (FATE) gains on positive data from cellular immunotherapies and preclinical study data.

BMY : 59.58 (-3.97%)
GILD : 72.66 (-2.73%)
FATE : 28.79 (-9.69%)
BLUE : 66.78 (-8.14%)

Van Meerten Stock Picks

My 5 Favorite Mid Caps
Summary 100% technical buy signals with current momentum.
CRUS -3.69 , SEDG -6.46 , THC -1.06 , TER -3.02 , LITE -2.73
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar